BSC Medical - Gateway to your medical needsNew and Used Medical Equipment

Latest News

Preceptis Medical announces first patient enrollment in the Hummingbird(TM) TTS Office Study for Ear Tube Delivery and new journal publication
Tue, 22 Aug 2017 12:45:21 GMT

PLYMOUTH, Minn., Aug. 22, 2017 -- (Healthcare Sales & Marketing Network) -- Preceptis Medical announces the enrollment of the first patient in a prospective, office-based study at Health Partners Clinic (St. Paul, MN) with Principal Investigator Frank Rim...
Preceptis Medical, Hummingbird TTS, Tympanostomy

Getinge announces full U.S. availability of Pulsar(R)-18 self-expanding stent from BIOTRONIK for patients with peripheral artery disease
Tue, 22 Aug 2017 12:34:35 GMT

Getinge expands partnership with BIOTRONIK as part of its commitment to provide healthcare providers with innovative solutions that help improve patient outcomes. WAYNE, N.J., Aug. 22, 2017 -- (Healthcare Sales & Marketing Network) -- Getinge, a leadin...
Devices, Interventional, Product Launch
Getinge, BIOTRONIK, Pulsar-18, stent , peripheral artery disease

BIOTRONIK US Launches Smallest MR Conditional Quadripolar Cardiac Resynchronization Therapy Pacemaker
Mon, 21 Aug 2017 15:43:08 GMT

Edora HF-T QP Completes BIOTRONIK's ProMRI Portfolio LAKE OSWEGO, Ore., Aug. 21, 2017 -- (Healthcare Sales & Marketing Network) -- BIOTRONIK today announced FDA approval and commercial availability of Edora HF-T QP, an MR conditional quadripolar (QP) c...
Devices, Cardiology, FDA, Product Launch
BIOTRONIK, Edora HF-T QP, cardiac resynchronization therapy, pacemaker

Perrigo Announces Final FDA Approval And Settlement For The Store Brand OTC Equivalent Of Nexium(R) 24HR Capsules
Mon, 21 Aug 2017 15:38:57 GMT

DUBLIN, Aug. 21, 2017 -- (Healthcare Sales & Marketing Network) -- Perrigo Company plc (NYSE; TASE: PRGO) today announced that it has received final approval from the U.S. Food & Drug Administration for the store brand OTC equivalent of Nexium® 24HR (...
Biopharmaceuticals, Generics, FDA, Litigation
Perrigo, esomeprazole, Nexium

Ethicon Launches ProxiSure(TM) Suturing Device Designed To Improve Precision In Minimally-Invasive Surgery
Mon, 21 Aug 2017 12:58:08 GMT

Advanced laparoscopic suturing device features Ethicon's innovative endomechanical, suture and curved needle technologies SOMERVILLE, N.J., Aug. 21, 2017 -- (Healthcare Sales & Marketing Network) -- Ethicon*, part of the Johnson & Johnson Medical Devic...
Devices, Surgery, Product Launch
Ethicon, Johnson & Johnson, ProxiSure, Suturing Device, laparoscopy

Cardiome Provides U.S. Regulatory Update For BRINAVESS
Mon, 21 Aug 2017 12:51:02 GMT

VANCOUVER, Aug. 21, 2017 -- (Healthcare Sales & Marketing Network) - Cardiome Pharma Corp. (NASDAQ: CRME/ TSX:COM) today announced that it has received a response from the U.S. Food and Drug Administration (FDA) regarding the regulatory path for BRINAVESS...
Biopharmaceuticals, Cardiology, FDA
Cardiome Pharma, BRINAVESS, vernakalant, atrial fibrillation

Gamida Cell Announces First Patient Transplanted in Phase 1/2 Study of CordIn for Severe Aplastic Anemia and Hypoplastic MDS
Mon, 21 Aug 2017 12:42:50 GMT

This investigator initiated study is being conducted in collaboration with the U.S. National Heart, Lung and Blood Institute (NHLBI) JERUSALEM, Aug. 21, 2017 -- (Healthcare Sales & Marketing Network) -- The first subject has been transplanted in an in...
Gamida Cell, Cordin, aplastic anemia, myelodysplastic syndrome

BioVentrix Announces First Patient Enrolled in IDE Study of the Revivent TC(TM) TransCatheter Ventricular Enhancement Treatment for Ischemic Cardiomyopathy
Mon, 21 Aug 2017 12:30:50 GMT

SAN RAMON, Calif. and CAMBRIDGE, England, Aug. 21, 2017 -- (Healthcare Sales & Marketing Network) -- BioVentrix, Inc. a pioneer of technologies and procedures for less invasive treatment of heart failure (HF), today announced enrollment of the first patie...
Devices, Cardiology
BioVentrix, Revivent TC, TransCatheter Ventricular Enhancement

EndoPredict(R) Receives Positive Coverage Decisions From Medicare and Anthem
Fri, 18 Aug 2017 15:21:02 GMT

Brings Total Coverage to Over 90 Percent of Breast Cancer Patients SALT LAKE CITY, Aug. 18, 2017 -- (Healthcare Sales & Marketing Network) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, announced tod...
Diagnostics, Oncology, Reimbursement
Myriad Genetics, EndoPredict, breast cancer

Prollenium Medical Technologies Inc. announces U.S. FDA approval for its cross-linked hyaluronic acid dermal filler
Fri, 18 Aug 2017 15:16:49 GMT

AURORA, ON, Aug. 18, 2017 -- (Healthcare Sales & Marketing Network) - Prollenium Medical Technologies Inc., a leading medical device manufacturer, announced today its United States (U.S.) Food and Drug Administration (FDA) approval for its cross-linked hy...
Devices, Dermatology, FDA
Prollenium Medical Technologies, hyaluronic acid, dermal filler

Source: HSMN NewsFeed